Together these data show a link between the mechanism responsible for neurodegeneration of L2-PD DAn and IL-6 signaling via IL-6R, and they shed light on the putative use of specific IL-6 blockers to significantly prevent DAn neurodegeneration in PD. Here, IL6R is linked to Parkinson disease.